top of page

Safety in Oncology Compounding: Where Biosimilar Brands Make the Difference

Johannes Roth
1 day ago
2 min read

Updated: 5 hours ago

In short: For a biosimilar manufacturer, CURTH+ROTH conducted the German part of an international ethnographic study in hospital pharmacies. We identified two areas with a particular risk of error: the compounding system and delivery to the ward. Our client was able to make its compounding system safer at low cost. And it now addresses pharmacists and pharmacy staff more precisely.

Two specialists in cleanroom clothing preparing an infusion at a biological safety cabinet in a hospital pharmacy

Illustrative image, AI-generated. To protect confidentiality, we do not show images from our projects.


The challenge

Hospital pharmacies compound cancer medications individually. Each preparation is based on a physician's order. Specialist pharmacists review every order again. Compounding itself involves many safety-critical steps. Several people are involved. Errors can occur anywhere between order and administration. Processes have improved steadily over the years. Still, every step remains demanding.

For biosimilars, the active substances are largely comparable across manufacturers. Brands can hardly stand out through the drug itself. The difference lies in how well a manufacturer supports the people who work with it.


Our approach

For an international study, CURTH+ROTH conducted the German part. In all countries, only senior researchers with ethnological expertise were involved. CURTH+ROTH has been working for years on hospital management systems, laboratory computers, mass spectrometers and HPLC. This gave our researchers a sharp eye for processes in clinical settings.

We closely observed the compounding process in hospital pharmacies. And we interviewed everyone involved. We then analyzed the findings and developed recommendations. Healthcare systems differ greatly from country to country. That is why local expertise is essential.


The results

We identified two areas with a particular risk of error.


Compounding system

Our client was able to improve it at low cost. This makes preparation considerably safer. The manufacturer can now show its users concrete support for safe work.


Delivery to the ward

Each preparation has to reach the right nurse or orderly. In large university hospitals, that is a challenge in itself. Delivery is time-critical. And it must be error-free. A wrong medication can have fatal consequences. We developed a concrete idea for more precise delivery. Precise delivery is also faster. That makes it both safer and more economical. Any manufacturer can adopt this idea. So the effect on the brand is smaller. But it shows what ethnographic research can achieve.


Communication

The interviews revealed even more. We learned what information pharmacists and pharmacy staff really need. And when and how they want to receive it. Our client can now address them more precisely.


Demanding research

Research in this field is demanding. Everyone on the team is carefully briefed. They understand the subject matter. They know regulatory requirements such as adverse event reporting. And we document the process without disclosing confidential information. We welcome these challenges.


The first step is a conversation.

Tell us your question. We'll tell you honestly whether and how we can answer it. research@curth-roth.de · +49 40 3600690

Comments


bottom of page